Meijer Fexofenadine Hydrochloride Allergy Relief Tablets Recalled
Meijer allergy relief tablets containing fexofenadine hydrochloride are being recalled nationwide due to out-of-specification impurity results found during stability testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard involves out-of-specification impurities detected during stability testing, which represents a precautionary quality issue rather than an acute safety threat with documented harm.
Plain-English summary
Perrigo Company PLC is recalling Meijer allergy relief fexofenadine hydrochloride 24HR 180mg antihistamine tablets distributed nationwide in the United States. The recall affects three bottle sizes: 15-count (NDC 41250-060-22, UPC 760236187165), 30-count (NDC 41250-060-39, UPC 760236187172), and 45-count (NDC 41250-060-95, UPC 760236187325) bottles. A total of 4,536 containers are affected.
The recall was initiated because stability testing revealed an out-of-specification result for impurity A. The affected lot numbers are: 0HE2530 (expiration 12/31/2021) and 0KE2430 (expiration 2/28/2022) for 15-count bottles; 0LR0362 (expiration 6/30/2022) and 1BR0462 (expiration 10/31/2022) for 30-count bottles; and 0FR0460 (expiration 2/28/2022) for 45-count bottles. The product was manufactured in the Czech Republic and distributed by Meijer Distribution Inc, Grand Rapids, Michigan.
Consumers who have purchased this product should stop using it and contact Meijer or Perrigo Company PLC with questions.
The recalled product
- Product
- Meijer allergy relief, Fexofenadine Hydrochloride tablets, 24HR, 1800mg Antihistamine, packaged as a) 15 count bottle, NDC 41250-060-22 UPC 7 60236 18716 5; b) 30 count bottle, NDC 41250-060-39, UPC 7 60236 18717 2; c) 45 count bottle, NDC 41250-060-95, UPC 7 60236 18732 5; Made
- Manufacturer
- Perrigo Company PLC
- Affected units
- 4,536
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot a) 0HE2530
- Exp 12/31/2021
- 0KE2430
- Exp 2/28/2022 b) 0LR0362
- Exp 6/30/2022
- 1BR0462
- Exp 10/31/2022 c) 0FR0460
- Exp 2/28/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 30 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · impurity degradation
See all →- Low
- ModerateEsomeprazole Magnesium oral suspension recalled for failed impurity specifications
FDA (Drugs) · 2025-05-28
- HighDiltiazem Hydrochloride extended-release capsules recalled due to failed quality specifications
FDA (Drugs) · 2023-02-08
- ModerateXiidra ophthalmic solution recalled for failed impurity and degradation specifications
FDA (Drugs) · 2022-06-15
- ModerateXiidra Ophthalmic Solution Recalled for Failed Impurity and Degradation Specifications
FDA (Drugs) · 2022-06-15